US20170172781A1 - Sweat pad and methods of using same - Google Patents

Sweat pad and methods of using same Download PDF

Info

Publication number
US20170172781A1
US20170172781A1 US14/970,831 US201514970831A US2017172781A1 US 20170172781 A1 US20170172781 A1 US 20170172781A1 US 201514970831 A US201514970831 A US 201514970831A US 2017172781 A1 US2017172781 A1 US 2017172781A1
Authority
US
United States
Prior art keywords
layer
subject
placing
contour
hemorrhoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/970,831
Other languages
English (en)
Inventor
Thomas A. Muldowney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemispheres For All LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US14/970,831 priority Critical patent/US20170172781A1/en
Priority to PCT/US2016/061970 priority patent/WO2017105721A1/en
Priority to CA3008671A priority patent/CA3008671A1/en
Priority to AU2016373824A priority patent/AU2016373824B2/en
Priority to MX2018007394A priority patent/MX2018007394A/es
Priority to CN201680071503.5A priority patent/CN108366881A/zh
Priority to EP16876297.9A priority patent/EP3389579A4/en
Priority to JP2018551754A priority patent/JP2019508187A/ja
Publication of US20170172781A1 publication Critical patent/US20170172781A1/en
Assigned to HEMISPHERES FOR ALL, LLC reassignment HEMISPHERES FOR ALL, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MULDOWNEY, THOMAS A
Assigned to HEMISPHERES FOR ALL, LLC reassignment HEMISPHERES FOR ALL, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHMITT, KARL R.
Priority to US29/710,453 priority patent/USD914205S1/en
Priority to US16/986,266 priority patent/US11298254B2/en
Priority to US29/770,822 priority patent/USD930155S1/en
Priority to US29/805,024 priority patent/USD966502S1/en
Priority to US17/688,876 priority patent/US11786389B2/en
Priority to US18/464,269 priority patent/US12239559B2/en
Priority to US18/965,682 priority patent/US20250090357A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/0093—Rectal devices, e.g. for the treatment of haemorrhoids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A61M35/006—Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6018—General characteristics of the apparatus with identification means providing set-up signals for the apparatus configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1042—Alimentary tract
    • A61M2210/1067—Anus

Definitions

  • the present disclosure relates to devices for absorbing a bodily fluid (e.g., sweat), relieving pain and/or itching, and/or relieving one or more symptoms of hemorrhoids.
  • a bodily fluid e.g., sweat
  • Sweating and itching around the anus is a common occurrence, and can be embarrassing to those who suffer from it and its other symptoms.
  • Hemorrhoids are also common, and often impart itching, pain, swelling and bleeding.
  • Other conditions such as proximal decubitus ulcers, also include symptoms emanating from the anal or perianal regions.
  • Surgical interventions are associated with increased risks of infection and other complications.
  • some conditions e.g., early stage hemorrhoids
  • are not indicated for surgical correction yet are associated with extreme discomfort for many subjects. A need exists for non-surgical treatments for these and other similar conditions.
  • the present disclosure provides devices for absorbing a bodily fluid (e.g., sweat), relieving pain and/or itching, and/or relieving one or more symptoms of hemorrhoids.
  • the device is placed adjacent to (e.g., in contact with) an existing hemorrhoid, or adjacent to (e.g., in contact with) a location of a subject where a hemorrhoid is likely to form.
  • the device absorbs fluid (e.g., sweat) when placed adjacent to (e.g., in contact with) skin of a subject.
  • the present disclosure provides an absorbent device comprising a first layer including a body-facing surface containing an anti-stick material; a second layer disposed opposite the first body-facing surface; and a third layer disposed between the first and second layers and comprising an absorbent material, wherein at least a portion of the first layer includes a contour that substantially deviates from a plane.
  • the present disclosure provide an absorbent device comprising a first, body-facing layer comprising a plurality of dimples; a second layer disposed opposite the first layer; and an inner core disposed between the first, body-facing layer and the second layer.
  • the present disclosure provides methods of treating or preventing a hemorrhoid in a subject, the method comprising placing a device as disclosed herein at least partially within an intergluteal cleft of a subject.
  • the present disclosure provides methods of absorbing a fluid proximal to an anus of a subject, the method comprising placing a device as disclosed herein at least partially within an intergluteal cleft of a subject.
  • the present disclosure provides methods of reducing or eliminating itching proximal to an anus of a subject, the method comprising placing a device as disclosed herein at least partially within an intergluteal cleft of a subject.
  • FIG. 1A shows a perspective view of the top side of one embodiment of a device according to the present technology.
  • FIG. 1B shows a perspective view of the bottom side of the device of FIG. 1A .
  • FIG. 2 shows a perspective and cross-sectional view of the device of FIGS. 1A and 1B .
  • FIG. 3A shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 3B shows an expanded perspective view of the device of FIG. 3A .
  • FIG. 4 shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 5 shows a perspective and cross-sectional view representative of various embodiments of devices according to the present technology.
  • FIG. 6 shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 7A shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 7B shows a perspective view of the device of FIG. 7A part-way through being folded into a usable configuration.
  • FIG. 7C shows a perspective view of the device of FIGS. 7A and 7B after being folded into a usable configuration.
  • FIG. 8 shows a perspective and cross-sectional view of the device of FIGS. 7A-7C .
  • FIG. 9 shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 10 shows a cross-sectional view of the device of FIG. 9 .
  • FIG. 11 shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 12A shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 12B shows another perspective view of the device of FIG. 12A .
  • FIG. 12C shows a side perspective view of the device of FIGS. 12A-12B .
  • FIG. 12D shows a top view of the device of FIGS. 12A-12C .
  • FIG. 12E shows a bottom view of the device of FIGS. 12A-12D .
  • FIG. 12F shows a cross-sectional perspective view of the device of FIGS. 12A-12E .
  • FIG. 13A shows a perspective view of another embodiment of a device according to the present technology.
  • FIG. 13B shows a user grasping a removal tab of the device of FIG. 13A .
  • FIG. 13C shows a variation of the device of FIGS. 13A-13B having more than one removal tab.
  • FIG. 13D shows a user grasping a removal tab of the device of FIG. 13B .
  • FIGS. 1A-13D Certain specific details are set forth in the following description and in FIGS. 1A-13D to provide a thorough understanding of various embodiments of the technology. For example, several embodiments of devices for treating or preventing hemorrhoids are described in detail below. The present technology, however, may be used in conjunction with other therapies, such as a surgical procedure, topical application of medicaments, and the like. Other details describing well-known structures and systems often associated with devices for application to skin or adjacent to skin have not been set forth in the following disclosure to avoid unnecessarily obscuring the description of the various embodiments of the technology. A person of ordinary skill in the art, therefore, will accordingly understand that the technology may have other embodiments with additional elements, or the technology may have other embodiments without several of the features shown and described below with reference to FIGS. 1A-13D .
  • devices of the present disclosure absorb fluid (e.g., sweat) from skin of a subject.
  • the skin includes skin proximal to the subject's anus (e.g., at least in part in the subject's intergluteal cleft).
  • devices according to the present disclosure are configured to be placed, at least in part, in a subject's intergluteal cleft (e.g., proximal to the subject's anus such as perianal tissue).
  • the fluid includes blood, sweat, feces, urine and/or pus.
  • a device according to the present disclosure is sized such that the portion most proximal to the subject's anus (e.g., a portion that is in contact with perianal skin) is proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • a device 10 comprises a first layer 100 and a second layer 200 disposed opposite the first layer 100 . At least a portion of the first layer 100 includes a contour 300 that deviates from a plane (e.g., from a flat planar surface).
  • the first layer 100 is oriented on the device 10 to be on contact with or adjacent to the subject.
  • the first layer 100 may be formed of any material suitable for direct contact with skin and allows moisture to penetrate through the first layer 100 .
  • the first layer 100 comprises cotton.
  • the first layer 100 includes a surface (e.g., a body-facing surface) 150 .
  • the surface 150 may include a coating, such as a waxy coating, to prevent the first layer 100 from adhering to the subject's skin too strongly.
  • the surface 150 includes a texture.
  • the texture increases the adherence of the device 10 to the skin of the subject.
  • the texture includes one or more dimples.
  • the first layer 100 further includes one or more informational markings 400 for providing information to the subject.
  • the informational markings 400 may indicate which side of the device 10 should be in contact with the subject's skin.
  • the first layer 100 further includes one or more orientation markings 500 for indicating to the subject how the device 10 should be oriented upon application.
  • the orientation markings 500 may include a line indicating the midline of the device 10 which should be aligned parallel to the intergluteal cleft.
  • the contour portion 300 of the first layer 100 deviates from a plane (e.g., from a flat planar surface) with respect to the remaining portions of the first layer 100 .
  • the contour portion 300 substantially protrudes from the first layer 100 .
  • the contour portion 300 protrudes from the first layer 100 to form a generally spheroid shape.
  • the contour portion 300 forms a different shape, such as a disc, a mound, a cone, a teardrop, or a combination thereof.
  • the contour portion 300 substantially recedes from the first layer 100 , for example to form a dent or divot in the first layer 100 .
  • the contour portion 300 includes a surface 350 that may optionally include a texture similar to that described with respect to surface 150 of the first layer 100 .
  • the surface 350 does not include a texture, even in embodiments where surface 150 includes a texture.
  • the contour portion 300 is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the second layer 200 of the device 10 may be formed of any durable material, optionally suitable for direct contact with skin, and which may allow the fluid to penetrate through the second layer 200 .
  • the second layer 200 comprises cotton.
  • the second layer 200 of the device 10 includes a second surface 250 which, in some embodiments, may include a coating (e.g., a waxy coating) to improve the integrity of the second layer 200 to mechanical- or fluid-driven degradation.
  • the second surface 250 includes a texture.
  • the texture increases the adherence of the device 10 to the skin of the subject, for example to improve handling and manipulation of the device 10 during application.
  • the texture includes one or more dimples.
  • the second layer 200 may include a second contour portion 600 which, in some embodiments, includes a contour that substantially deviates from a plane (e.g., from a planar surface defined at least in part by the remainder of the second layer 200 ). For example, as shown in FIG. 1B , the second contour portion 600 may recede from a planar surface defined by the remainder of the second layer 200 such that an indentation is formed in the second layer 200 .
  • the second contour portion 600 includes a surface 650 that may optionally include a texture, such as one or more dimples, to improve handling and manipulation of the device 10 during application.
  • the second layer 200 further includes one or more informational markings 450 for providing information to the subject.
  • the informational markings 450 may indicate where the subject might apply pressure to properly install the device 10 in an intergluteal cleft.
  • the second layer 200 further includes one or more graphical indicators 550 for indicating to the subject how the device 10 should be oriented upon application.
  • the orientation markings 550 may indicate a central zone indicating the center of the device 10 , which should ideally be aligned with the anus of the subject upon application.
  • the first layer 100 and the second layer 200 may be secured to each other around the periphery by any suitable means known to those of skill in the art.
  • the first layer 100 and the second layer 200 are joined together by a seam or seal 255 .
  • the seam or seal 255 may be a physical joint (e.g., a sewn seam) or a chemical joint (e.g., an adhesive-enabled seal).
  • the first layer 100 and the second layer 200 are joined together by heat and/or compression.
  • the device 10 includes a cross-sectional shape defined by the first layer 100 , the second layer 200 and the contour 300 .
  • the cross-sectional shape may be chosen to enhance ease of use (e.g., installation and/or removal) of the device 10 , subjects' comfort, etc.
  • the cross-sectional shape is substantially round, ovoid, rod-shaped, or polygonal.
  • the cross-sectional shape may include a circle, an oval, a rod, a rectangle, a square, a trapezoid, a rhombus, a parallelogram, a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a squircle, a portion of any of the forgoing (e.g., a semi-circle), a tapered configuration of any of the foregoing, or a combination of two or more of any of the foregoing (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • the embodiment of FIGS. 1A-1B includes a third layer 700 disposed between the first layer 100 and the second layer 200 .
  • the third layer 700 includes a filler material 750 for absorbing fluids and/or delivering an active agent to the subject upon application of the device 10 in the subject's intergluteal cleft.
  • the third layer 700 occupies the entire space between the first layer 100 and the second layer 200 .
  • the filler material 750 comprises only a portion of the third layer 700 (e.g., occupies only a portion of the space between the first layer 100 and the second layer 200 ).
  • the remainder of the space between the first layer 100 and the second layer 200 not occupied by the filler material 750 may comprise a second filler material 800 , which may be a relatively firm, structurally supportive material like cotton or a foam, for securing the filler material 750 in a desired location within the device 10 .
  • the third layer 700 may comprise an absorbent material 750 such as cotton, located substantially within the non-planar contour portion 300 of the first layer 100 .
  • the third layer 700 further includes a second filler material 800 which is significantly more rigid than the absorbent material 750 .
  • the more rigid second filler material 800 substantially prevents the absorbent material 750 from being forced out of its original location within the device 10 by, for example, physical forces exerted by a subject's gluteal muscles on the device 10 .
  • a device 20 in another embodiment, shown in FIGS. 3A-3B , comprises a first layer 100 and a second layer 200 disposed opposite the first layer 100 . At least a portion of the first layer 100 includes a contour 300 that deviates from a plane (e.g., from a flat planar surface).
  • first layer 100 the second layer 200 , and the third layer 700 are substantially as described above with respect to FIGS. 1A-2 .
  • a third layer 700 is disposed between the first layer 100 and the second layer 200 , substantially in alignment with the contour portion 300 of the first layer 100 .
  • the contour portion 300 of the first layer 100 is formed at least in part by the presence of the third layer 700 between the first layer 100 and the second layer 200 .
  • the third layer 700 comprises a shape that is substantially discoid.
  • the third layer 700 may be a round or circular pouch containing an absorbent material (as described above with respect to FIGS. 1A-2 ) that is secured between the first layer 100 and the second layer 200 , causing the contour portion 300 of the first layer 100 to adopt a substantially discoid shape.
  • the first layer 100 and second layer 200 may be a continuous or semi-continuous form (e.g., without a flattened seam or seal 255 as shown in FIG. 1B ) to form a device 30 having rounded edges.
  • the contour portion 300 A may adopt any desired shape including, for example, a recessed cavity.
  • the first layer 100 , second layer 200 , and/or the contour portion 300 A may each include a surface 150 , a surface 250 (not shown due to perspective) and/or a surface 350 , respectively, as described above with respect to other embodiments.
  • the contour portion 300 A is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the second layer 200 may include a contour portion 300 B in addition to, or instead of, the contour portion 300 A of the first layer 100 .
  • the two contour portions 300 A/ 300 B may have an identical shape.
  • the two contour portions 300 A/ 300 B may have a substantially similar shape, or substantially different shapes.
  • the contour portion 300 A/ 300 B is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the device 30 may include an inner core 700 . Any remaining space between the first layer 100 and the second layer 200 may be filled with an absorbent filler material 800 .
  • the absorbent filler material 800 acts to draw fluid into the device 30 through the first layer 100 and/or the second layer 200 and eventually to the inner core 700 , for example along moisture paths 900 .
  • the inner core 700 may include a hygroscopic material 750 , such as cotton or any other aqueous absorbent material or combination of materials.
  • the inner core 700 may include an active agent 760 .
  • the active agent 760 is a deodorant.
  • the active agent 760 is an antibacterial agent.
  • the active agent 760 is a hemorrhoid relief agent (e.g., disaccharide polysulfide).
  • the active agent 760 is a numbing agent (e.g., a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as amethocaine).
  • the active agent is two or more or three or more of: a deodorant, an antibacterial agent, and a hemorrhoid relief agent.
  • the active agent comprises a deodorant, an antibacterial agent, a hemorrhoid relief agent and a numbing agent.
  • a device 40 in another embodiment, shown in FIG. 6 , comprises a substantially bulbous head portion 42 and a substantially narrow tail portion 44 .
  • the tail portion 44 enables safe and efficient handling of the device 40 , for example between a subject's thumb and forefinger, while remaining discreet after application within the subject's intergluteal cleft.
  • the device 40 may include a first layer 100 , a second layer 200 , and a contour portion 300 , similar to those shown and described above with respect to FIGS. 1A-5 .
  • General features of the first layer 100 , the second layer 200 , and the contour portion 300 , including surfaces 150 , 250 and 350 , are substantially as described above with respect to other illustrated embodiments.
  • the device 50 includes a bifurcated first layer 100 A/ 100 B comprising an absorbent material and an optional coating (e.g., a waxy coating) suitable for direct contact with skin.
  • Each of the bifurcated first layers 100 A and 100 B may include a surface 150 A/ 150 B.
  • the surfaces 150 A/ 150 B may have properties similar to those described above with respect to surface 150 in other embodiments.
  • the device 50 also includes a bifurcated contour portion 300 A/ 300 B which, after folding is complete (e.g., as shown in FIG. 7C ), has properties substantially similar to contour portion 300 in other embodiments described herein. More specifically, each of contour portions 300 A/ 300 B may have a surface 350 A/ 350 B that includes a texture, such as a plurality of dimples.
  • the bifurcated contour portion 300 A/ 300 B after the device 50 is folded as shown in FIG. 7C , is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the subject folds the device 50 along foldable crease 55 until the contour portion 300 A is in contact with and/or continuous with the contour portion 300 B, according to a progression shown in FIG. 7A to FIG. 7B to FIG. 7C .
  • the resulting folded device 50 ( FIG. 7C ) is then inserted within the intergluteal cleft such that the contour portion 300 A/ 300 B is in contact with the perianal tissue.
  • the foldable crease 55 imparts a hinged outward force (e.g., a residual hinged spring force) which further enhances the stability of the device 50 in its installed position within the intergluteal cleft.
  • the device 50 may include a bifurcated second layer 200 A/ 200 B disposed opposite the bifurcated first layer 100 A/ 100 B.
  • the bifurcated second layer 200 A/ 200 B may be substantially the same as second layer 200 as described above with respect to other embodiments.
  • bifurcated second layer 200 A may include a surface 250 A
  • bifurcated second layer 200 B may include a surface 250 B (not shown due to perspective) similar to or identical to second surface 250 described elsewhere in the present disclosure.
  • the bifurcated contour portions 300 A/ 300 B may each include an inner core 700 A/ 700 B, which may each be substantially similar to inner core 700 described in connection with other embodiments disclosed herein.
  • inner core 700 A/ 700 B may include a hygroscopic material 750 A/ 750 B and optionally an active agent 760 A/ 760 B, all encapsulated in a permeable barrier layer 740 A/ 740 B.
  • an absorbent material 800 A/ 800 B is disposed between the permeable barrier layer 740 A/ 740 B and the first layer 100 A/ 100 B and optionally between the permeable barrier layer 740 A/ 740 B and the second layer 200 A/ 200 B.
  • An optional active agent 760 A/ 760 B may be included within the hygroscopic material 750 A/ 750 B. In some embodiments, active agent 760 A is the same as the active agent 760 B. In other embodiments, the active agent 760 A is different than the active agent 760 B.
  • a device 60 in yet another embodiment, shown representatively in FIGS. 9-10 , comprises first layer 100 including a surface 150 .
  • the surface 150 includes at least one valley 152 and at least one plateau 154 for controlling flow of fluid into the device 60 .
  • the device 60 also optionally includes a pair of adhesive areas 156 for providing additional adherence to the subject's skin upon application.
  • the plateau portion(s) 154 may include a hydrophobic coating 158 which may attenuate the first layer 100 material's innate aqueous permeability properties.
  • the valley(s) 152 may not include the hydrophobic coating 158 , enabling relatively easier permeability of fluids through the first layer 100 and/or the second layer 200 and into the third layer 700 .
  • this relative permeability difference between the plateau portions 154 and the valley portion(s) 152 is represented by moisture paths 900 .
  • the third layer 700 may include a hygroscopic material 750 and optionally an active agent 760 .
  • a device 70 comprises a first layer 100 and a second layer 200 disposed opposite the first layer 100 .
  • Each of the first layer 100 and the second layer 200 may include a surface 150 and a surface 250 , respectively, which may have properties similar to those described above in connection with other disclosed embodiments.
  • the first layer 100 includes a contour portion 300 A, which may additionally include one or more pillars 360 A and one or more cavities 370 A between the pillars 360 A. Fluid absorbed by the contour portion 300 A may thus cause the pillars 360 A to expand radially, and the cavities 370 A to shrink accordingly.
  • the second layer 200 includes a contour portion 300 B, which may additionally include one or more pillars 360 B and one or more cavities 370 B between the pillars 360 B. Fluid absorbed by the contour portion 300 B may thus cause the pillars 360 B to expand radially, and the cavities 370 B to shrink accordingly.
  • the first layer 100 and the second layer 200 , and especially contour portions 300 A/ 300 B may absorb substantial amounts of fluid without substantially expanding (e.g., without a diameter D of the combined contour portions 300 A/ 300 B substantially increasing).
  • the contour portion 300 A/ 300 B is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the present disclosure provides another embodiment of a device 80 for absorbing a fluid from skin of a subject.
  • the device 80 is formed of a substantially uniform sheet of material.
  • the device 80 comprises a top surface 8100 which includes a contour portion 8300 .
  • the top surface 8100 may be formed of any material suitable for direct contact with skin and allows moisture to penetrate into the device 80 .
  • the top surface 8100 comprises cotton.
  • the top surface 8100 includes a surface (e.g., a body-facing surface) 8150 .
  • the surface 8150 may include a coating, such as a waxy coating, to prevent the top surface 8100 from adhering to the subject's skin too strongly.
  • the surface 8150 includes a texture.
  • the texture increases the adherence of the device 80 to the skin of the subject.
  • the texture includes one or more dimples.
  • the top surface 8100 further includes one or more informational markings 8400 for providing information to the subject.
  • the informational markings 8400 may indicate which side of the device 80 should be in contact with the subject's skin.
  • the top surface 8100 further includes one or more orientation markings 8500 for indicating to the subject how the device 80 should be oriented upon application.
  • the orientation markings 8500 may include a line indicating the midline of the device 80 which should be aligned parallel to the intergluteal cleft.
  • the contour portion 8300 of the top surface 8100 deviates from a plane (e.g., from a flat planar surface) with respect to the remaining portions of the top surface 8100 , or deviates from the contour of the remaining portions of the top surface 8100 .
  • the contour portion 8300 substantially protrudes from the top surface 8100 .
  • the contour portion 8300 protrudes from the top surface 8100 to form a generally spheroid shape.
  • the contour portion 8300 forms a different shape, such as a disc, a mound, a cone, a teardrop, or a combination thereof.
  • the contour portion 8300 substantially recedes from the top surface 8100 , for example to form a dent or divot in the top surface 8100 .
  • the contour portion 8300 includes a surface 8350 that may optionally include a texture similar to that described with respect to surface 8150 of the top surface 8100 .
  • the surface 8350 does not include a texture, even in embodiments where surface 8150 includes a texture.
  • the contour portion 8300 is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the bottom surface 8200 of the device 80 may be formed of any durable material, optionally suitable for direct contact with skin, and which may allow the fluid to penetrate through the bottom surface 8200 .
  • the bottom surface 8200 comprises cotton.
  • the bottom surface 8200 of the device 80 includes a second surface 8250 which, in some embodiments, may include a coating (e.g., a waxy coating) to improve the integrity of the second layer 8200 to mechanical- or fluid-driven degradation. In such embodiments, the coating prevents fluid from penetrating from the interior of the device 80 through the bottom surface 8200 (e.g., trapping absorbed fluid within the device 80 ).
  • the second surface 8250 includes a texture. In some embodiments, the texture increases the adherence of the device 80 to the skin of the subject, for example to improve handling and manipulation of the device 80 during application and/or removal. In some embodiments, the texture includes one or more dimples.
  • the bottom surface 8200 may include a second contour portion 8600 which, in some embodiments, includes a contour that substantially deviates from a plane (e.g., from a planar surface defined at least in part by the remainder of the bottom surface 8200 ) or deviates from the contour of the remaining portions of the bottom surface 8200 .
  • the second contour portion 8600 may recede from a planar surface defined by the remainder of the bottom surface 8200 such that an indentation is formed in the bottom surface 8200 .
  • the second contour portion 8600 includes a surface 8650 that may optionally include a texture, such as one or more dimples, to improve handling and manipulation of the device 80 during application and/or removal.
  • the bottom surface 8200 further includes one or more informational markings 8450 for providing information to the subject.
  • the informational markings 8450 may indicate a midline of the device 80 and/or may indicate where the subject might apply pressure to properly install the device 80 in an intergluteal cleft.
  • the bottom surface 8200 further includes one or more graphical indicators 8550 for indicating to the subject how the device 80 should be oriented upon application.
  • the orientation markings 8550 may indicate a central zone indicating the center of the device 80 , which should ideally be aligned with the anus of the subject upon application.
  • the device 80 may additionally include an inner core 8700 . Any remaining space between the top surface 8100 and the bottom surface 8200 may be filled by the inner core 8700 .
  • the inner core 8700 may comprise an absorbent material such as cotton, located substantially within the contour portion 8300 , 8600 of the device 80 .
  • the inner core 8700 may include an active agent such as a deodorant and/or an antibacterial agent.
  • the inner core 8700 may include a hygroscopic material, such as cotton or any other aqueous absorbent material or combination of materials.
  • the inner core 8700 may include an active agent.
  • the active agent is a deodorant.
  • the active agent is an antibacterial agent.
  • the active agent is a hemorrhoid relief agent (e.g., disaccharide polysulfide).
  • the active agent is a numbing agent (e.g., a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as amethocaine).
  • the active agent is two or more or three or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • the active agent comprises a deodorant, an antibacterial agent, a hemorrhoid relief agent and a numbing agent.
  • the device 80 includes a cross-sectional shape defined by the top surface 8100 , the bottom surface 8200 , the inner core 8700 , and the contour portions 8300 , 8600 .
  • the cross-sectional shape may be chosen to enhance ease of use (e.g., installation and/or removal) of the device 80 , subjects' comfort, etc.
  • the cross-sectional shape may be an arched dome-like shape having a substantially uniform thickness.
  • the cross-sectional shape may alternatively include a circle, an oval, a rod, a rectangle, a square, a trapezoid, a rhombus, a parallelogram, a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a squircle, a portion of any of the forgoing (e.g., a semi-circle), a tapered configuration of any of the foregoing, or a combination of two or more of any of the foregoing (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • any device disclosed herein may additionally include one or more creases.
  • the term “crease” refers to an indentation, fold, or overlapping region of the material.
  • a crease 8055 may include only a portion of the thickness of the material (e.g., a crease in only one layer of a multilayer device). In other embodiments, a crease may extend through the entire thickness of the device (e.g., through all layers of a multilayer device).
  • the creases enable the device to absorb substantially more fluid from skin of the subject than a comparably sized and shaped device that does not include creases, or alternatively includes fewer creases or creases of smaller dimension (e.g., length, width, volume and/or surface area).
  • the creases are formed my converting (e.g., molding) a substantially flat piece of the sheet of material to form a contoured shaped, such as that generally shown in any one of FIGS. 1A-12F .
  • the device 80 includes at least four creases 8055 .
  • the device 80 includes at least two creases 8055 , such as about three creases 8055 , about four creases 8055 , about five creases 8055 , about six creases 8055 , about seven creases 8055 , about eight creases 8055 , about nine creases 8055 , about ten creases 8055 , or more than about ten creases 8055 .
  • the present disclosure provides another embodiment of a device 90 for absorbing a fluid from skin of a subject.
  • the device 90 is formed of a substantially uniform sheet of material.
  • the device 90 comprises a top surface 9100 which includes a contour portion 9300 .
  • the top surface 9100 may be formed of any material suitable for direct contact with skin and allows moisture to penetrate into the device 90 .
  • the top surface 9100 comprises cotton.
  • the top surface 9100 includes a surface (e.g., a body-facing surface) 9150 .
  • the surface 9150 may include a coating, such as a waxy coating, to prevent the top surface 9100 from adhering to the subject's skin too strongly.
  • the surface 9150 includes a texture.
  • the texture increases the adherence of the device 90 to the skin of the subject.
  • the texture includes one or more dimples.
  • the top surface 9100 further includes one or more orientation markings 9500 for indicating to the subject how the device 90 should be oriented upon application.
  • the orientation markings 9500 may include a line indicating a midline of the device 90 which should be aligned parallel to or, as specifically shown in FIGS. 13A-13D , perpendicular to the intergluteal cleft.
  • the contour portion 9300 of the top surface 9100 deviates from a plane (e.g., from a flat planar surface) with respect to the remaining portions of the top surface 9100 , or deviates from the contour of the remaining portions of the top surface 9100 .
  • the contour portion 9300 may substantially protrude from the top surface 9100 .
  • the contour portion 9300 protrudes from the top surface 9100 to form a generally spheroid shape.
  • the contour portion 9300 forms a different shape, such as a disc, a mound, a cone, a teardrop, or a combination thereof.
  • the contour portion 9300 substantially recedes from the top surface 9100 , for example to form a dent or divot in the top surface 9100 .
  • the contour portion 9300 includes a surface 9350 that may optionally include a texture similar to that described with respect to surface 9150 of the top surface 9100 .
  • the surface 9350 does not include a texture, even in embodiments where surface 9150 includes a texture.
  • the contour portion 9300 is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the bottom surface 9200 of the device 90 may be formed of any durable material, optionally suitable for direct contact with skin, and which may allow the fluid to penetrate through the bottom surface 9200 .
  • the bottom surface 9200 comprises cotton.
  • the bottom surface 9200 of the device 90 includes a second surface 9250 which, in some embodiments, may include a coating (e.g., a waxy coating) to improve the integrity of the second layer 9200 to mechanical- or fluid-driven degradation. In such embodiments, the coating prevents fluid from penetrating from the interior of the device 90 through the bottom surface 9200 (e.g., trapping absorbed fluid within the device 90 ).
  • the second surface 9250 includes a texture. In some embodiments, the texture increases the adherence of the device 90 to the skin of the subject, for example to improve handling and manipulation of the device 90 during application and/or removal. In some embodiments, the texture includes one or more dimples.
  • the bottom surface 9200 may include a second contour portion 9600 which, in some embodiments, includes a contour that substantially deviates from a plane (e.g., from a planar surface defined at least in part by the remainder of the bottom surface 9200 ) or deviates from the contour of the remaining portions of the bottom surface 9200 .
  • the second contour portion 9600 may recede from a planar surface defined by the remainder of the bottom surface 9200 such that an indentation is formed in the bottom surface 9200 .
  • the second contour portion 9600 includes a surface 9650 that may optionally include a texture, such as one or more dimples, to improve handling and manipulation of the device 80 during application and/or removal.
  • the device 90 includes one or more removal tabs 9900 , for example integrated with or attached to the bottom surface 9200 .
  • the one or more removal tabs 9900 enable the user to more easily remove the device 90 after use, for example when the device 90 has absorbed fluid.
  • the device 90 includes a single removal tab 9900 connected to the bottom surface 9200 at or near the center of the bottom surface 9200 (e.g., within the second contour portion 9600 ).
  • the user grasps the removal tab 9900 with his or her hand H and pulls the removal tab 9900 in a direction generally away from the intergluteal cleft.
  • the device 90 may include more than one removal tab 9900 , such as two removal tabs 9900 .
  • the two removal tabs 9900 may be connected to the device 90 at any suitable location, preferably symmetrically opposed in relation to the center of the device 90 .
  • one removal tab 9900 a may be attached to one edge E of the bottom surface 9200
  • a second removal tab 9900 b may be attached to a generally opposite edge E′ of the bottom surface 9200 .
  • the user grasps the first removal tab 9900 a , the second removal tab 9900 b , or both removal tabs 9900 a , 9900 b with his or her hand H, and pulls in a direction generally away from the intergluteal cleft.
  • the bottom surface 9200 further includes one or more informational markings 9450 for providing information to the subject.
  • the informational markings 9450 may indicate a midline of the device 90 and/or may indicate where the subject might apply pressure to properly install the device 90 in an intergluteal cleft.
  • the bottom surface 9200 further includes one or more graphical indicators 9550 for indicating to the subject how the device 90 should be oriented upon application.
  • the orientation markings 9550 may indicate a central zone indicating the center of the device 90 , which should ideally be aligned with the anus of the subject upon application.
  • the device 90 may additionally include other features described with respect to the embodiments shown in FIGS. 1-12F , such as an inner core identical to or similar to the inner core 8700 of device 80 .
  • the optional inner core of device 90 may include an active agent such as a deodorant, an antibacterial agent, a hemorrhoid relief agent, and/or a numbing agent.
  • the active agent is two or more or three or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • the active agent comprises a deodorant, an antibacterial agent, a hemorrhoid relief agent and a numbing agent.
  • the device 90 includes a cross-sectional shape defined by the top surface 9100 , the bottom surface 9200 , the inner core 9700 , and the contour portions 9300 , 9600 .
  • the cross-sectional shape may be chosen to enhance ease of use (e.g., installation and/or removal) of the device 90 , subjects' comfort, etc.
  • the cross-sectional shape may be an arched dome-like shape having a substantially uniform thickness.
  • the cross-sectional shape may alternatively include a circle, an oval, a rod, a rectangle, a square, a trapezoid, a rhombus, a parallelogram, a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a squircle, a portion of any of the forgoing (e.g., a semi-circle), a tapered configuration of any of the foregoing, or a combination of two or more of any of the foregoing (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • Device 90 may also include one or more creases 9055 , which may optionally include only a portion of the thickness of the material (e.g., a crease in only one layer of a multilayer device). In other embodiments, the one or more crease 9055 may extend through the entire thickness of the device 90 . In some embodiments, the crease(s) 9055 enable the device 90 to absorb substantially more fluid from skin of the subject than a comparably sized and shaped device that does not include creases, or alternatively includes fewer creases or creases of smaller dimension (e.g., length, width, volume and/or surface area).
  • the crease(s) 9055 are formed my converting (e.g., molding) a substantially flat piece of the sheet of material to form a contoured shaped, such as that generally shown in any one of FIGS. 13A-13D .
  • the device 90 may include a single crease 9055 , or alternatively may include at least two creases 9055 , such as about three creases 9055 , about four creases 9055 , about five creases 9055 , about six creases 9055 , about seven creases 9055 , about eight creases 9055 , about nine creases 9055 , about ten creases 9055 , or more than about ten creases 9055 .
  • the present disclosure provides an absorbent device comprising a first layer including a body-facing surface containing an anti-stick material; a second layer disposed opposite the first body-facing surface; and a third layer disposed between the first and second layers and comprising an absorbent material.
  • the first layer includes a contour that substantially deviates from a plane.
  • the third layer further includes an inner core comprising a hygroscopic material.
  • the inner core is separated from the absorbent material by a barrier material.
  • the inner core further includes an active agent.
  • the active agent comprises a deodorant and/or an antibacterial agent.
  • the first layer includes a graphic element for providing application information to a user.
  • the second layer includes a graphic element for providing application information to a user.
  • the second layer includes a graphic element for providing application information to a user.
  • the body-facing surface includes a plurality of dimples. In some embodiments, the body-facing surface does not include an adhesive portion. In some embodiments, the contour that substantially deviates from a plane is spheroid.
  • the present disclosure provides an absorbent device comprising a first, body-facing layer comprising a plurality of dimples; a second layer disposed opposite the first layer; and an inner core disposed between the first, body-facing layer and the second layer.
  • the first, body-facing layer does not include an adhesive portion.
  • the inner core layer comprises an absorbent material and optionally an active agent.
  • the absorbent material comprises cornstarch.
  • the active agent comprises a deodorant and/or antibacterial agent.
  • at least one of the first, body-facing layer and the second layer includes a graphic element for providing application information to a user.
  • Devices disclosed herein may be used to absorb fluid (e.g., sweat, blood, feces, urine and/or pus) from skin (e.g., perianal skin) of a subject.
  • the method may include applying a device as diagnosed herein to the intergluteal cleft of a subject such that at least a portion of the device is in contact with skin proximal to the subject's anus (e.g., intergluteal skin).
  • the present disclosure provides a method of absorbing a fluid proximal to an anus of a subject, the method comprising placing a device as disclosed herein at least partially within an intergluteal cleft of the subject.
  • the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • the method further comprises leaving the device in contact with skin of the subject for a period of time sufficient to absorb a fluid from the skin of the subject.
  • the fluid includes sweat, blood, feces, urine and/or pus.
  • the method further comprises removing the device after the period of time. In some embodiments, the device is removed within 24 hours of the step of placing the device within the intergluteal cleft.
  • Sweating and itching are common co-symptoms and, as such, methods of the present disclosure may simultaneously or substantially simultaneously absorb a fluid (e.g., sweat, blood, feces, urine and/or pus) from skin of the subject and reduce or eliminate itching proximal to the subject's anus.
  • a fluid e.g., sweat, blood, feces, urine and/or pus
  • the method reduces or eliminates itching without absorbing a fluid from skin proximal to the subject's anus, for example when the subject experiences itching but not fluid secretion.
  • the method comprises placing a device as disclosed herein at least partially within an intergluteal cleft of the subject.
  • the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • the method further comprises leaving the device in contact with skin of the subject for a period of time sufficient to reduce or eliminate the itching. In some embodiments, the method further comprises removing the device after the period of time. In some embodiments, the device is removed within 24 hours of the step of placing the device within the intergluteal cleft.
  • the method of absorbing fluid proximal to the anus comprises placing the device at least partially within the intergluteal cleft of the subject before fluid is present near the anus (e.g., before onset of sweating and/or itching symptoms).
  • the fluid may be absorbed by the device to substantially or completely prevent sweating and/or itching symptoms.
  • the present disclosure provides a method of preventing recurrence of itching in a subject.
  • the method comprises placing a device as disclosed herein at least partially within an intergluteal cleft of the subject.
  • the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • the method further comprises leaving the device in contact with skin of the subject for a period of time sufficient to reduce or eliminate the itching.
  • the method further comprises removing the device after the period of time.
  • the device is removed within 24 hours of the step of placing the device within the intergluteal cleft.
  • the device may be inserted at least partially within the subject's intergluteal cleft and, after a period of time sufficient to absorb fluid from the intergluteal cleft, removed and discarded. If needed, a second, unused device as disclosed herein may be inserted at least partially within the subject's intergluteal cleft to absorb additional intergluteal fluid.
  • the method further absorbs and/or neutralizes odors, for example by use of a device as disclosed herein that includes an antibacterial active agent.
  • the method provides intergluteal fluid absorption sufficient to reduce, minimize, or prevent intergluteal fluid from contacting the subject's clothing (e.g., undergarment and/or outer wear).
  • the fluid may comprise sweat.
  • the fluid may consist essentially of sweat.
  • the fluid may consist of sweat.
  • the present disclosure provides a method of absorbing fluid (e.g., sweat) from an intergluteal cleft of a subject, the method comprising placing a device as disclosed herein at least partially within an intergluteal cleft of a subject.
  • the device is placed in contact with perianal tissue of the subject and/or in contact with a hemorrhoid of the subject.
  • devices of the present disclosure treat or prevent hemorrhoids in a subject.
  • the device is configured to be placed, at least in part, in a subject's intergluteal cleft.
  • the device is configured to be placed in contact with a hemorrhoid to at least partially relieve a symptom of the hemorrhoid, such as itching, bleeding, burning, pain and/or swelling.
  • the device is configured to be placed in contact with a hemorrhoid to prevent progression (e.g., worsening) of the hemorrhoid.
  • the device is configured to be placed in contact with at least a portion of the subject's perianal tissue to prevent emergence of a hemorrhoid.
  • a device 10 for treating or preventing hemorrhoids in a subject comprises a first layer 100 and a second layer 200 disposed opposite the first layer 100 . At least a portion of the first layer 100 includes a contour 300 that deviates from a plane (e.g., from a flat planar surface).
  • the first layer 100 is oriented on the device 10 to be on contact with or adjacent to the subject.
  • the first layer 100 may be formed of any material suitable for direct contact with skin and allows moisture to penetrate through the first layer 100 .
  • the first layer 100 comprises cotton.
  • the first layer 100 includes a surface (e.g., a body-facing surface) 150 .
  • the surface 150 may include a coating, such as a waxy coating, to prevent the first layer 100 from adhering to the subject's skin too strongly.
  • the surface 150 includes a texture.
  • the texture increases the adherence of the device 10 to the skin of the subject.
  • the texture includes one or more dimples.
  • the first layer 100 further includes one or more informational markings 400 for providing information to the subject.
  • the informational markings 400 may indicate which side of the device 10 should be in contact with the subject's skin.
  • the first layer 100 further includes one or more orientation markings 500 for indicating to the subject how the device 10 should be oriented upon application.
  • the orientation markings 500 may include a line indicating the midline of the device 10 which should be aligned parallel to the intergluteal cleft.
  • the contour portion 300 of the first layer 100 deviates from a plane (e.g., from a flat planar surface) with respect to the remaining portions of the first layer 100 .
  • the contour portion 300 substantially protrudes from the first layer 100 .
  • the contour portion 300 protrudes from the first layer 100 to form a generally spheroid shape.
  • the contour portion 300 forms a different shape or cross-sectional profile, such as a disc, a mound, a cone, a teardrop, a polygon, a quadrilateral (e.g., a rectangle, a square, a trapezoid, a rhombus, a parallelogram, etc.), a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a truncated polygon, a tapered configuration of any of the foregoing, or a combination thereof (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • a quadrilateral e.g., a rectangle, a square, a trapezoid, a rhombus, a parallelogram, etc.
  • a triangle e.g., a hexagon,
  • the contour portion 300 substantially recedes from the first layer 100 , for example to form a dent or divot in the first layer 100 .
  • the contour portion 300 includes a surface 350 that may optionally include a texture similar to that described with respect to surface 150 of the first layer 100 .
  • the surface 350 does not include a texture, even in embodiments where surface 150 includes a texture.
  • the contour portion 300 is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the second layer 200 of the device 10 may be formed of any durable material, optionally suitable for direct contact with skin, and which may allow moisture to penetrate through the second layer 200 .
  • the second layer 200 comprises cotton.
  • the second layer 200 of the device 10 includes a second surface 250 which, in some embodiments, may include a coating (e.g., a waxy coating) to improve the integrity of the second layer 200 to mechanical- or fluid-driven degradation.
  • the second surface 250 includes a texture.
  • the texture increases the adherence of the device 10 to the skin of the subject, for example to improve handling and manipulation of the device 10 during application.
  • the texture includes one or more dimples.
  • the second layer 200 may include a second contour portion 600 which, in some embodiments, includes a contour that substantially deviates from a plane (e.g., from a planar surface defined at least in part by the remainder of the second layer 200 ). For example, as shown in FIG. 1B , the second contour portion 600 may recede from a planar surface defined by the remainder of the second layer 200 such that an indentation is formed in the second layer 200 .
  • the second contour portion 600 includes a surface 650 that may optionally include a texture, such as one or more dimples, to improve handling and manipulation of the device 10 during application.
  • the second layer 200 further includes one or more informational markings 450 for providing information to the subject.
  • the informational markings 450 may indicate where the subject might apply pressure to properly install the device 10 in an intergluteal cleft.
  • the second layer 200 further includes one or more graphical indicators 550 for indicating to the subject how the device 10 should be oriented upon application.
  • the orientation markings 550 may indicate a central zone indicating the center of the device 10 , which should ideally be aligned with the anus of the subject upon application.
  • the first layer 100 and the second layer 200 may be secured to each other around the periphery by any suitable means known to those of skill in the art.
  • the first layer 100 and the second layer 200 are joined together by a seam or seal 255 .
  • the seam or seal 255 may be a physical joint (e.g., a sewn seam) or a chemical joint (e.g., an adhesive-enabled seal).
  • the first layer 100 and the second layer 200 are joined together by heat and/or compression.
  • the device 10 includes a cross-sectional shape defined by the first layer 100 , the second layer 200 and the contour 300 .
  • the cross-sectional shape may be chosen to enhance ease of use (e.g., installation and/or removal) of the device 10 , subjects' comfort, etc.
  • the cross-sectional shape is substantially round, ovoid, rod-shaped, or polygonal.
  • the cross-sectional shape may include a circle, an oval, a rod, a rectangle, a square, a trapezoid, a rhombus, a parallelogram, a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a squircle, a portion of any of the forgoing (e.g., a semi-circle), a tapered configuration of any of the foregoing, or a combination of two or more of any of the foregoing (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • the embodiment of FIGS. 1A-1B includes a third layer 700 disposed between the first layer 100 and the second layer 200 .
  • the third layer 700 includes a filler material 750 for absorbing fluids and/or delivering an active agent to the subject upon application of the device 10 in the subject's intergluteal cleft.
  • the third layer 700 occupies the entire space between the first layer 100 and the second layer 200 .
  • the filler material 750 comprises only a portion of the third layer 700 (e.g., occupies only a portion of the space between the first layer 100 and the second layer 200 ).
  • the remainder of the space between the first layer 100 and the second layer 200 not occupied by the filler material 750 may comprise a second filler material 800 , which may be a relatively firm, structurally supportive material like cotton or a foam, for securing the filler material 750 in a desired location within the device 10 .
  • the third layer 700 may comprise an absorbent material 750 such as cotton, located substantially within the non-planar contour portion 300 of the first layer 100 .
  • the third layer 700 further includes a second filler material 800 which is significantly more rigid than the absorbent material 750 .
  • the more rigid second filler material 800 substantially prevents the absorbent material 750 from being forced out of its original location within the device 10 by, for example, physical forces exerted by a subject's gluteal muscles on the device 10 .
  • a device 20 for treating or preventing hemorrhoids in a subject comprises a first layer 100 and a second layer 200 disposed opposite the first layer 100 . At least a portion of the first layer 100 includes a contour 300 that deviates from a plane (e.g., from a flat planar surface).
  • first layer 100 the second layer 200 , and the third layer 700 are substantially as described above with respect to FIGS. 1A-2 .
  • a third layer 700 is disposed between the first layer 100 and the second layer 200 , substantially in alignment with the contour portion 300 of the first layer 100 .
  • the contour portion 300 of the first layer 100 is formed at least in part by the presence of the third layer 700 between the first layer 100 and the second layer 200 .
  • the third layer 700 comprises a shape that is substantially discoid.
  • the third layer 700 may be a round or circular pouch containing an absorbent material (as described above with respect to FIGS. 1A-2 ) that is secured between the first layer 100 and the second layer 200 , causing the contour portion 300 of the first layer 100 to adopt a substantially discoid shape.
  • the first layer 100 and second layer 200 may be a continuous or semi-continuous form (e.g., without a flattened seam or seal 255 as shown in FIG. 1B ) to form a device 30 having rounded edges.
  • the contour portion 300 A may adopt any desired shape including, for example, a recessed cavity.
  • the first layer 100 , second layer 200 , and/or the contour portion 300 A may each include a surface 150 , a surface 250 (not shown due to perspective) and/or a surface 350 , respectively, as described above with respect to other embodiments.
  • the contour portion 300 A is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the second layer 200 may include a contour portion 300 B in addition to, or instead of, the contour portion 300 A of the first layer 100 .
  • the two contour portions 300 A/ 300 B may have an identical shape.
  • the two contour portions 300 A/ 300 B may have a substantially similar shape, or substantially different shapes.
  • the contour portion 300 A/ 300 B is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the device 30 may include an inner core 700 . Any remaining space between the first layer 100 and the second layer 200 may be filled with an absorbent filler material 800 .
  • the absorbent filler material 800 acts to draw fluid into the device 30 through the first layer 100 and/or the second layer 200 and eventually to the inner core 700 , for example along moisture paths 900 .
  • the inner core 700 may include a hygroscopic material 750 , such as cotton or any other aqueous absorbent material or combination of materials.
  • the inner core 700 may include an active agent 760 .
  • the active agent 760 is a deodorant.
  • the active agent 760 is an antibacterial agent.
  • the active agent 760 is a hemorrhoid relief agent (e.g., disaccharide polysulfide).
  • the active agent 760 is a numbing agent (e.g., a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as amethocaine).
  • the active agent is two or more or three or more of: a deodorant, an antibacterial agent, and a hemorrhoid relief agent.
  • the active agent comprises a deodorant, an antibacterial agent, a hemorrhoid relief agent and a numbing agent.
  • a device 40 in another embodiment for treating or preventing hemorrhoids in a subject, shown in FIG. 6 , comprises a substantially bulbous head portion 42 and a substantially narrow tail portion 44 .
  • the tail portion 44 enables safe and efficient handling of the device 40 , for example between a subject's thumb and forefinger, while remaining discreet after application within the subject's intergluteal cleft.
  • the device 40 may include a first layer 100 , a second layer 200 , and a contour portion 300 , similar to those shown and described above with respect to FIGS. 1A-5 .
  • General features of the first layer 100 , the second layer 200 , and the contour portion 300 , including surfaces 150 , 250 and 350 , are substantially as described above with respect to other illustrated embodiments.
  • a device 50 for treating or preventing hemorrhoids in a subject includes a foldable crease 55 along a length of the device 50 for enabling efficient packaging of the device 50 .
  • the device 50 includes a bifurcated first layer 100 A/ 100 B comprising an absorbent material and an optional coating (e.g., a waxy coating) suitable for direct contact with skin.
  • Each of the bifurcated first layers 100 A and 100 B may include a surface 150 A/ 150 B.
  • the surfaces 150 A/ 150 B may have properties similar to those described above with respect to surface 150 in other embodiments.
  • the device 50 also includes a bifurcated contour portion 300 A/ 300 B which, after folding is complete (e.g., as shown in FIG. 7C ), has properties substantially similar to contour portion 300 in other embodiments described herein. More specifically, each of contour portions 300 A/ 300 B may have a surface 350 A/ 350 B that includes a texture, such as a plurality of dimples.
  • the bifurcated contour portion 300 A/ 300 B after the device 50 is folded as shown in FIG. 7C , is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the subject folds the device 50 along foldable crease 55 until the contour portion 300 A is in contact with and/or continuous with the contour portion 300 B, according to a progression shown in FIG. 7A to FIG. 7B to FIG. 7C .
  • the resulting folded device 50 ( FIG. 7C ) is then inserted within the intergluteal cleft such that the contour portion 300 A/ 300 B is in contact with the perianal tissue and/or a hemorrhoid.
  • the foldable crease 55 imparts a hinged outward force (e.g., a residual hinged spring force) which further enhances the stability of the device 50 in its installed position within the intergluteal cleft.
  • the device 50 may include a bifurcated second layer 200 A/ 200 B disposed opposite the bifurcated first layer 100 A/ 100 B.
  • the bifurcated second layer 200 A/ 200 B may be substantially the same as second layer 200 as described above with respect to other embodiments.
  • bifurcated second layer 200 A may include a surface 250 A
  • bifurcated second layer 200 B may include a surface 250 B (not shown due to perspective) similar to or identical to second surface 250 described elsewhere in the present disclosure.
  • the bifurcated contour portions 300 A/ 300 B may each include an inner core 700 A/ 700 B, which may each be substantially similar to inner core 700 described in connection with other embodiments disclosed herein.
  • inner core 700 A/ 700 B may include a hygroscopic material 750 A/ 750 B and optionally an active agent 760 A/ 760 B, all encapsulated in a permeable barrier layer 740 A/ 740 B.
  • an absorbent material 800 A/ 800 B is disposed between the permeable barrier layer 740 A/ 740 B and the first layer 100 A/ 100 B and optionally between the permeable barrier layer 740 A/ 740 B and the second layer 200 A/ 200 B.
  • An optional active agent 760 A/ 760 B may be included within the hygroscopic material 750 A/ 750 B. In some embodiments, active agent 760 A is the same as the active agent 760 B. In other embodiments, the active agent 760 A is different than the active agent 760 B.
  • a device 60 in yet another embodiment for treating or preventing hemorrhoids in a subject, shown representatively in FIGS. 9-10 , comprises first layer 100 including a surface 150 .
  • the surface 150 includes at least one valley 152 and at least one plateau 154 for controlling flow of fluid into the device 60 .
  • the device 60 also optionally includes a pair of adhesive areas 156 for providing additional adherence to the subject's skin upon application.
  • the plateau portion(s) 154 may include a hydrophobic coating 158 which may attenuate the first layer 100 material's innate aqueous permeability properties.
  • the valley(s) 152 may not include the hydrophobic coating 158 , enabling relatively easier permeability of aqueous fluids through the first layer 100 and/or the second layer 200 and into the third layer 700 .
  • this relative permeability difference between the plateau portions 154 and the valley portion(s) 152 is represented by moisture paths 900 .
  • the third layer 700 may include a hygroscopic material 750 and optionally an active agent 760 .
  • a device 70 in yet another embodiment for treating or preventing hemorrhoids in a subject, shown representatively in FIG. 11 , a device 70 according to the present technology comprises a first layer 100 and a second layer 200 disposed opposite the first layer 100 .
  • Each of the first layer 100 and the second layer 200 may include a surface 150 and a surface 250 , respectively, which may have properties similar to those described above in connection with other disclosed embodiments.
  • the first layer 100 includes a contour portion 300 A, which may additionally include one or more pillars 360 A and one or more cavities 370 A between the pillars 360 A. Fluid absorbed by the contour portion 300 A may thus cause the pillars 360 A to expand radially, and the cavities 370 A to shrink accordingly.
  • the second layer 200 includes a contour portion 300 B, which may additionally include one or more pillars 360 B and one or more cavities 370 B between the pillars 360 B. Fluid absorbed by the contour portion 300 B may thus cause the pillars 360 B to expand radially, and the cavities 370 B to shrink accordingly.
  • the first layer 100 and the second layer 200 , and especially contour portions 300 A/ 300 B may absorb substantial amounts of fluid without substantially expanding (e.g., without a diameter D of the combined contour portions 300 A/ 300 B substantially increasing).
  • the contour portion 300 A/ 300 B is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • a device 80 for treating or preventing hemorrhoids in a subject is formed of a substantially uniform sheet of material.
  • the device 80 comprises a top surface 8100 which includes a contour portion 8300 .
  • the top surface 8100 may be formed of any material suitable for direct contact with skin and allows moisture to penetrate into the device 80 .
  • the top surface 8100 comprises cotton.
  • the top surface 8100 includes a surface (e.g., a body-facing surface) 8150 .
  • the surface 8150 may include a coating, such as a waxy coating, to prevent the top surface 8100 from adhering to the subject's skin too strongly.
  • the surface 8150 includes a texture.
  • the texture increases the adherence of the device 80 to the skin of the subject.
  • the texture includes one or more dimples.
  • the top surface 8100 further includes one or more informational markings 8400 for providing information to the subject.
  • the informational markings 8400 may indicate which side of the device 80 should be in contact with the subject's skin.
  • the top surface 8100 further includes one or more orientation markings 8500 for indicating to the subject how the device 80 should be oriented upon application.
  • the orientation markings 8500 may include a line indicating the midline of the device 80 which should be aligned parallel to the intergluteal cleft.
  • the contour portion 8300 of the top surface 8100 deviates from a plane (e.g., from a flat planar surface) with respect to the remaining portions of the top surface 8100 , or deviates from the contour of the remaining portions of the top surface 8100 .
  • the contour portion 8300 substantially protrudes from the top surface 8100 .
  • the contour portion 8300 protrudes from the top surface 8100 to form a generally spheroid shape.
  • the contour portion 8300 forms a different shape, such as a disc, a mound, a cone, a teardrop, or a combination thereof.
  • the contour portion 8300 substantially recedes from the top surface 8100 , for example to form a dent or divot in the top surface 8100 .
  • the contour portion 8300 includes a surface 8350 that may optionally include a texture similar to that described with respect to surface 8150 of the top surface 8100 .
  • the surface 8350 does not include a texture, even in embodiments where surface 8150 includes a texture.
  • the contour portion 8300 is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the bottom surface 8200 of the device 80 may be formed of any durable material, optionally suitable for direct contact with skin, and which may allow the fluid to penetrate through the bottom surface 8200 .
  • the bottom surface 8200 comprises cotton.
  • the bottom surface 8200 of the device 80 includes a second surface 8250 which, in some embodiments, may include a coating (e.g., a waxy coating) to improve the integrity of the second layer 8200 to mechanical- or fluid-driven degradation. In such embodiments, the coating prevents fluid from penetrating from the interior of the device 80 through the bottom surface 8200 (e.g., trapping absorbed fluid within the device 80 ).
  • the second surface 8250 includes a texture. In some embodiments, the texture increases the adherence of the device 80 to the skin of the subject, for example to improve handling and manipulation of the device 80 during application and/or removal. In some embodiments, the texture includes one or more dimples.
  • the bottom surface 8200 may include a second contour portion 8600 which, in some embodiments, includes a contour that substantially deviates from a plane (e.g., from a planar surface defined at least in part by the remainder of the bottom surface 8200 ) or deviates from the contour of the remaining portions of the bottom surface 8200 .
  • the second contour portion 8600 may recede from a planar surface defined by the remainder of the bottom surface 8200 such that an indentation is formed in the bottom surface 8200 .
  • the second contour portion 8600 includes a surface 8650 that may optionally include a texture, such as one or more dimples, to improve handling and manipulation of the device 80 during application and/or removal.
  • the bottom surface 8200 further includes one or more informational markings 8450 for providing information to the subject.
  • the informational markings 8450 may indicate a midline of the device 80 and/or may indicate where the subject might apply pressure to properly install the device 80 in an intergluteal cleft.
  • the bottom surface 8200 further includes one or more graphical indicators 8550 for indicating to the subject how the device 80 should be oriented upon application.
  • the orientation markings 8550 may indicate a central zone indicating the center of the device 80 , which should ideally be aligned with the anus of the subject upon application.
  • the device 80 may additionally include an inner core 8700 . Any remaining space between the top surface 8100 and the bottom surface 8200 may be filled by the inner core 8700 .
  • the inner core 8700 may comprise an absorbent material such as cotton, located substantially within the contour portion 8300 , 8600 of the device 80 .
  • the inner core 8700 may include an active agent such as a deodorant and/or an antibacterial agent.
  • the inner core 8700 may include a hygroscopic material, such as cotton or any other aqueous absorbent material or combination of materials.
  • the inner core 8700 may include an active agent.
  • the active agent is a deodorant.
  • the active agent is an antibacterial agent.
  • the active agent is a hemorrhoid relief agent (e.g., disaccharide polysulfide).
  • the active agent is a numbing agent (e.g., a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as amethocaine).
  • the active agent is two or more or three or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • the active agent comprises a deodorant, an antibacterial agent, a hemorrhoid relief agent and a numbing agent.
  • the device 80 includes a cross-sectional shape defined by the top surface 8100 , the bottom surface 8200 , the inner core 8700 , and the contour portions 8300 , 8600 .
  • the cross-sectional shape may be chosen to enhance ease of use (e.g., installation and/or removal) of the device 80 , subjects' comfort, etc.
  • the cross-sectional shape may be an arched dome-like shape having a substantially uniform thickness.
  • the cross-sectional shape may alternatively include a circle, an oval, a rod, a rectangle, a square, a trapezoid, a rhombus, a parallelogram, a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a squircle, a portion of any of the forgoing (e.g., a semi-circle), a tapered configuration of any of the foregoing, or a combination of two or more of any of the foregoing (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • any device disclosed herein may additionally include one or more creases.
  • the term “crease” refers to an indentation, fold, or overlapping region of the material.
  • a crease 8055 may include only a portion of the thickness of the material (e.g., a crease in only one layer of a multilayer device). In other embodiments, a crease may extend through the entire thickness of the device (e.g., through all layers of a multilayer device).
  • the creases enable the device to absorb substantially more fluid from skin of the subject than a comparably sized and shaped device that does not include creases, or alternatively includes fewer creases or creases of smaller dimension (e.g., length, width, volume and/or surface area).
  • the creases are formed my converting (e.g., molding) a substantially flat piece of the sheet of material to form a contoured shaped, such as that generally shown in any one of FIGS. 1A-12F .
  • the device 80 includes at least four creases 8055 .
  • the device 80 includes at least two creases 8055 , such as about three creases 8055 , about four creases 8055 , about five creases 8055 , about six creases 8055 , about seven creases 8055 , about eight creases 8055 , about nine creases 8055 , about ten creases 8055 , or more than about ten creases 8055 .
  • the present disclosure provides another embodiment of a device 90 for absorbing a fluid from skin of a subject.
  • the device 90 is formed of a substantially uniform sheet of material.
  • the device 90 comprises a top surface 9100 which includes a contour portion 9300 .
  • the top surface 9100 may be formed of any material suitable for direct contact with skin and allows moisture to penetrate into the device 90 .
  • the top surface 9100 comprises cotton.
  • the top surface 9100 includes a surface (e.g., a body-facing surface) 9150 .
  • the surface 9150 may include a coating, such as a waxy coating, to prevent the top surface 9100 from adhering to the subject's skin too strongly.
  • the surface 9150 includes a texture.
  • the texture increases the adherence of the device 90 to the skin of the subject.
  • the texture includes one or more dimples.
  • the top surface 9100 further includes one or more orientation markings 9500 for indicating to the subject how the device 90 should be oriented upon application.
  • the orientation markings 9500 may include a line indicating a midline of the device 90 which should be aligned parallel to or, as specifically shown in FIGS. 13A-13D , perpendicular to the intergluteal cleft.
  • the contour portion 9300 of the top surface 9100 deviates from a plane (e.g., from a flat planar surface) with respect to the remaining portions of the top surface 9100 , or deviates from the contour of the remaining portions of the top surface 9100 .
  • the contour portion 9300 may substantially protrude from the top surface 9100 .
  • the contour portion 9300 protrudes from the top surface 9100 to form a generally spheroid shape.
  • the contour portion 9300 forms a different shape, such as a disc, a mound, a cone, a teardrop, or a combination thereof.
  • the contour portion 9300 substantially recedes from the top surface 9100 , for example to form a dent or divot in the top surface 9100 .
  • the contour portion 9300 includes a surface 9350 that may optionally include a texture similar to that described with respect to surface 9150 of the top surface 9100 .
  • the surface 9350 does not include a texture, even in embodiments where surface 9150 includes a texture.
  • the contour portion 9300 is sized proportional to the subject's size (e.g., the subject's height, weight, BMI, waist circumference, etc.).
  • the bottom surface 9200 of the device 90 may be formed of any durable material, optionally suitable for direct contact with skin, and which may allow the fluid to penetrate through the bottom surface 9200 .
  • the bottom surface 9200 comprises cotton.
  • the bottom surface 9200 of the device 90 includes a second surface 9250 which, in some embodiments, may include a coating (e.g., a waxy coating) to improve the integrity of the second layer 9200 to mechanical- or fluid-driven degradation. In such embodiments, the coating prevents fluid from penetrating from the interior of the device 90 through the bottom surface 9200 (e.g., trapping absorbed fluid within the device 90 ).
  • the second surface 9250 includes a texture. In some embodiments, the texture increases the adherence of the device 90 to the skin of the subject, for example to improve handling and manipulation of the device 90 during application and/or removal. In some embodiments, the texture includes one or more dimples.
  • the bottom surface 9200 may include a second contour portion 9600 which, in some embodiments, includes a contour that substantially deviates from a plane (e.g., from a planar surface defined at least in part by the remainder of the bottom surface 9200 ) or deviates from the contour of the remaining portions of the bottom surface 9200 .
  • the second contour portion 9600 may recede from a planar surface defined by the remainder of the bottom surface 9200 such that an indentation is formed in the bottom surface 9200 .
  • the second contour portion 9600 includes a surface 9650 that may optionally include a texture, such as one or more dimples, to improve handling and manipulation of the device 80 during application and/or removal.
  • the device 90 includes one or more removal tabs 9900 , for example integrated with or attached to the bottom surface 9200 .
  • the one or more removal tabs 9900 enable the user to more easily remove the device 90 after use, for example when the device 90 has absorbed fluid.
  • the device 90 includes a single removal tab 9900 connected to the bottom surface 9200 at or near the center of the bottom surface 9200 (e.g., within the second contour portion 9600 ).
  • the user grasps the removal tab 9900 with his or her hand H and pulls the removal tab 9900 in a direction generally away from the intergluteal cleft.
  • the device 90 may include more than one removal tab 9900 , such as two removal tabs 9900 .
  • the two removal tabs 9900 may be connected to the device 90 at any suitable location, preferably symmetrically opposed in relation to the center of the device 90 .
  • one removal tab 9900 a may be attached to one edge E of the bottom surface 9200
  • a second removal tab 9900 b may be attached to a generally opposite edge E′ of the bottom surface 9200 .
  • the user grasps the first removal tab 9900 a , the second removal tab 9900 b , or both removal tabs 9900 a , 9900 b with his or her hand H, and pulls in a direction generally away from the intergluteal cleft.
  • the bottom surface 9200 further includes one or more informational markings 9450 for providing information to the subject.
  • the informational markings 9450 may indicate a midline of the device 90 and/or may indicate where the subject might apply pressure to properly install the device 90 in an intergluteal cleft.
  • the bottom surface 9200 further includes one or more graphical indicators 9550 for indicating to the subject how the device 90 should be oriented upon application.
  • the orientation markings 9550 may indicate a central zone indicating the center of the device 90 , which should ideally be aligned with the anus of the subject upon application.
  • the device 90 may additionally include other features described with respect to the embodiments shown in FIGS. 1-12F , such as an inner core identical to or similar to the inner core 8700 of device 80 .
  • the optional inner core of device 90 may include an active agent such as a deodorant, an antibacterial agent, a hemorrhoid relief agent, and/or a numbing agent.
  • the active agent is two or more or three or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • the active agent comprises a deodorant, an antibacterial agent, a hemorrhoid relief agent and a numbing agent.
  • the device 90 includes a cross-sectional shape defined by the top surface 9100 , the bottom surface 9200 , the inner core 9700 , and the contour portions 9300 , 9600 .
  • the cross-sectional shape may be chosen to enhance ease of use (e.g., installation and/or removal) of the device 90 , subjects' comfort, etc.
  • the cross-sectional shape may be an arched dome-like shape having a substantially uniform thickness.
  • the cross-sectional shape may alternatively include a circle, an oval, a rod, a rectangle, a square, a trapezoid, a rhombus, a parallelogram, a triangle, a hexagon, a pentagon, a heptagon, an octagon, a nonagon, a squircle, a portion of any of the forgoing (e.g., a semi-circle), a tapered configuration of any of the foregoing, or a combination of two or more of any of the foregoing (e.g., a cross-sectional profile including a quadrilateral portion and one or more protruding finger-like portion from one of the quadrilateral lengths and/or corners).
  • Device 90 may also include one or more creases 9055 , which may optionally include only a portion of the thickness of the material (e.g., a crease in only one layer of a multilayer device). In other embodiments, the one or more crease 9055 may extend through the entire thickness of the device 90 . In some embodiments, the crease(s) 9055 enable the device 90 to absorb substantially more fluid from skin of the subject than a comparably sized and shaped device that does not include creases, or alternatively includes fewer creases or creases of smaller dimension (e.g., length, width, volume and/or surface area).
  • the crease(s) 9055 are formed my converting (e.g., molding) a substantially flat piece of the sheet of material to form a contoured shaped, such as that generally shown in any one of FIGS. 13A-13D .
  • the device 90 may include a single crease 9055 , or alternatively may include at least two creases 9055 , such as about three creases 9055 , about four creases 9055 , about five creases 9055 , about six creases 9055 , about seven creases 9055 , about eight creases 9055 , about nine creases 9055 , about ten creases 9055 , or more than about ten creases 9055 .
  • the present disclosure provides an absorbent device comprising a first layer including a body-facing surface containing an anti-stick material; a second layer disposed opposite the first body-facing surface; and a third layer disposed between the first and second layers and comprising an absorbent material.
  • the first layer includes a contour that substantially deviates from a plane.
  • the third layer further includes an inner core comprising a hygroscopic material.
  • the inner core is separated from the absorbent material by a barrier material.
  • the inner core further includes an active agent.
  • the active agent comprises one or more of: a deodorant, an antibacterial agent, and a hemorrhoid relief agent.
  • the first layer includes a graphic element for providing application information to a user.
  • the second layer includes a graphic element for providing application information to a user.
  • the second layer includes a graphic element for providing application information to a user.
  • the body-facing surface includes a plurality of dimples. In some embodiments, the body-facing surface does not include an adhesive portion. In some embodiments, the contour that substantially deviates from a plane is spheroid.
  • the present disclosure provides an absorbent device comprising a first, body-facing layer comprising a plurality of dimples; a second layer disposed opposite the first layer; and an inner core disposed between the first, body-facing layer and the second layer.
  • the first, body-facing layer does not include an adhesive portion.
  • the inner core layer comprises an absorbent material and optionally an active agent.
  • the absorbent material comprises cornstarch.
  • the active agent comprises one or more of: a deodorant, an antibacterial agent, and a hemorrhoid relief agent.
  • at least one of the first, body-facing layer and the second layer includes a graphic element for providing application information to a user.
  • Devices disclosed herein may be used to treat or prevent a hemorrhoid in a subject.
  • the method may include applying a device as diagnosed herein to the intergluteal cleft of a subject such that at least a portion of the device is in contact with the hemorrhoid.
  • the method comprises placing the device at least partially within the intergluteal cleft of the subject before a hemorrhoid develops (e.g., before onset of hemorrhoid-related pain and/or itching symptoms).
  • the subject is at increased risk of developing hemorrhoids.
  • the subject has one or more hemorrhoid risk factors: constipation, low fiber diet, high fat diet, obesity, sedentary lifestyle, dehydration, alcoholism, pregnancy, recent childbirth, diarrhea, damage or atrophy of pelvic floor muscle (e.g., from recent surgery, pregnancy or childbirth), heart disease, liver disease, age of 50 years or older, and/or family history of hemorrhoids.
  • the method comprises providing a device as disclosed herein to a subject in need of treatment or prevention of hemorrhoids, and instructing the subject to insert the device at least partially within the intergluteal cleft.
  • the method results in an attenuation of one or more symptoms associated with the hemorrhoid, such as pain, itching, and/or swelling.
  • the method results in a downgrade of the hemorrhoid grade.
  • a grade 3 hemorrhoid of a subject may, after treatment according to the present disclosure, be reduced to a grade 2 hemorrhoid.
  • the method results in a delay (e.g., a substantial delay) in the need for a clinical procedure to remove the hemorrhoid.
  • the clinical procedure is selected from the group consisting of: rubber band ligation, sclerotherapy, cauterization, hemorrhoidectomy, hemorrhoidal dearterialization, and stapled hemorrhoidopexy.
  • a method of treating a hemorrhoid as disclosed herein further excludes a clinical intervention to treat the hemorrhoid.
  • the clinical intervention is selected from the group consisting of: rubber band ligation, sclerotherapy, cauterization, hemorrhoidectomy, hemorrhoidal dearterialization, and stapled hemorrhoidopexy.
  • the present disclosure provides a method of treating or preventing a hemorrhoid in a subject, the method comprising placing a device as disclosed herein at least partially within an intergluteal cleft of a subject. In some embodiments, the device is placed in contact with a hemorrhoid of the subject and/or in contact with perianal tissue of the subject.
  • the device includes a numbing agent (e.g., a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as amethocaine)).
  • a numbing agent e.g., a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as amethocaine)).
  • a topical anesthetic such as benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, and tetracaine (alternatively referred to as
  • any method disclosed herein may also be used to treat and/or prevent one or more symptoms associated with a disorder other than hemorrhoids.
  • the disorder is one or more of: fissures, fistulae, abscesses, colorectal cancer, rectal varices, itching, rectal bleeding, colitis, inflammatory bowel disease, diverticular disease, and angiodysplasia.
  • An absorbent device comprising a first layer including a body-facing surface containing an anti-stick material; a second layer disposed opposite the first body-facing surface; and a third layer disposed between the first and second layers and comprising an absorbent material, wherein at least a portion of the first layer includes a contour that substantially deviates from a plane.
  • Example 1 The device of Example 1, wherein the third layer further includes an inner core comprising a hygroscopic material.
  • Example 2 The device of Example 2, wherein the inner core is separated from the absorbent material by a barrier material.
  • Example 1 The device of Example 1, wherein the inner core further includes an active agent.
  • Example 4 wherein the active agent comprises one or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • the active agent comprises one or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • Example 1 The device of Example 1, wherein the first layer includes a graphic element for providing application information to a user.
  • Example 1 The device of Example 1, wherein the second layer includes a graphic element for providing application information to a user.
  • Example 6 The device of Example 6, wherein the second layer includes a graphic element for providing application information to a user.
  • Example 1 The device of Example 1, wherein the body-facing surface includes a plurality of dimples.
  • Example 1 The device of Example 1, wherein the body-facing surface does not include an adhesive portion.
  • Example 1 The device of Example 1, wherein the contour that substantially deviates from a plane is spheroid.
  • Example 1 The device of Example 1, wherein the second layer further comprises one or more removal tabs.
  • Example 1 The device of Example 1, wherein the first layer further comprises one or more creases.
  • An absorbent device comprising a first, body-facing layer comprising a plurality of dimples; a second layer disposed opposite the first layer; and an inner core disposed between the first, body-facing layer and the second layer.
  • Example 14 wherein the first, body-facing layer does not include an adhesive portion.
  • Example 14 wherein the inner core layer comprises an absorbent material and optionally an active agent.
  • Example 16 wherein the active agent comprises one or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • the active agent comprises one or more of: a deodorant, an antibacterial agent, a hemorrhoid relief agent, and a numbing agent.
  • Example 14 wherein at least one of the first, body-facing layer and the second layer includes a graphic element for providing application information to a user.
  • Example 14 The device of Example 14, wherein the second layer further comprises one or more removal tabs.
  • Example 14 The device of Example 14, wherein the first layer further comprises one or more creases.
  • a method of treating or preventing a hemorrhoid in a subject comprising:
  • Example 22 wherein the step of placing the device further includes placing the device in contact with a hemorrhoid of the subject and/or in contact with perianal tissue of the subject.
  • a method of treating or preventing a hemorrhoid in a subject comprising placing a device according to Example 14 at least partially within an intergluteal cleft of a subject.
  • Example 24 wherein the step of placing the device further includes placing the device in contact with a hemorrhoid of the subject and/or in contact with perianal tissue of the subject.
  • a method of absorbing a fluid proximal to an anus of a subject comprising placing a device according to Example 1 at least partially within an intergluteal cleft of a subject.
  • Example 26 wherein the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • a method of absorbing a fluid proximal to an anus of a subject comprising placing a device according to Example 14 at least partially within an intergluteal cleft of a subject.
  • Example 28 wherein the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • a method of preventing, reducing or eliminating itching proximal to an anus of a subject comprising placing a device according to Example 1 at least partially within an intergluteal cleft of a subject.
  • Example 30 wherein the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • a method of preventing, reducing or eliminating itching proximal to an anus of a subject comprising placing a device according to Example 14 at least partially within an intergluteal cleft of a subject.
  • Example 32 wherein the step of placing the device further includes placing the device in contact with perianal skin of the subject.
  • treatment in relation a given disease or disorder, includes, but is not limited to, inhibiting the disease or disorder, for example, arresting the development of the disease or disorder; relieving the disease or disorder, for example, causing regression of the disease or disorder; or relieving a condition caused by or resulting from the disease or disorder, for example, relieving, preventing or treating symptoms of the disease or disorder.
  • prevention in relation to a given disease or disorder means: preventing the onset of disease development if none had occurred, preventing the disease or disorder from occurring in a subject that may be predisposed to the disorder or disease but has not yet been diagnosed as having the disorder or disease, and/or preventing further disease/disorder development if already present.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nursing (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
US14/970,831 2015-12-16 2015-12-16 Sweat pad and methods of using same Abandoned US20170172781A1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
US14/970,831 US20170172781A1 (en) 2015-12-16 2015-12-16 Sweat pad and methods of using same
JP2018551754A JP2019508187A (ja) 2015-12-16 2016-11-15 汗パッド及びこれを使用する方法
CA3008671A CA3008671A1 (en) 2015-12-16 2016-11-15 Sweat pad and methods of using same
AU2016373824A AU2016373824B2 (en) 2015-12-16 2016-11-15 Sweat pad and methods of using same
MX2018007394A MX2018007394A (es) 2015-12-16 2016-11-15 Almohadilla para el sudor y metodos para su utilizacion.
PCT/US2016/061970 WO2017105721A1 (en) 2015-12-16 2016-11-15 Sweat pad and methods of using same
CN201680071503.5A CN108366881A (zh) 2015-12-16 2016-11-15 汗垫及其使用方法
EP16876297.9A EP3389579A4 (en) 2015-12-16 2016-11-15 ANTI-SWEAT PAD AND METHODS OF USING THE SAME
US29/710,453 USD914205S1 (en) 2015-12-16 2019-10-23 Absorbent pad
US16/986,266 US11298254B2 (en) 2015-12-16 2020-08-06 Sweat pad and methods of using same
US29/770,822 USD930155S1 (en) 2015-12-16 2021-02-17 Absorbent pad
US29/805,024 USD966502S1 (en) 2015-12-16 2021-08-24 Absorbent pad
US17/688,876 US11786389B2 (en) 2015-12-16 2022-03-07 Sweat pad and methods of using same
US18/464,269 US12239559B2 (en) 2015-12-16 2023-09-11 Sweat pad and methods of using same
US18/965,682 US20250090357A1 (en) 2015-12-16 2024-12-02 Sweat pad and methods of using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/970,831 US20170172781A1 (en) 2015-12-16 2015-12-16 Sweat pad and methods of using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US29/710,453 Continuation-In-Part USD914205S1 (en) 2015-12-16 2019-10-23 Absorbent pad
US16/986,266 Division US11298254B2 (en) 2015-12-16 2020-08-06 Sweat pad and methods of using same

Publications (1)

Publication Number Publication Date
US20170172781A1 true US20170172781A1 (en) 2017-06-22

Family

ID=59057822

Family Applications (5)

Application Number Title Priority Date Filing Date
US14/970,831 Abandoned US20170172781A1 (en) 2015-12-16 2015-12-16 Sweat pad and methods of using same
US16/986,266 Active 2036-02-25 US11298254B2 (en) 2015-12-16 2020-08-06 Sweat pad and methods of using same
US17/688,876 Active 2035-12-17 US11786389B2 (en) 2015-12-16 2022-03-07 Sweat pad and methods of using same
US18/464,269 Active US12239559B2 (en) 2015-12-16 2023-09-11 Sweat pad and methods of using same
US18/965,682 Pending US20250090357A1 (en) 2015-12-16 2024-12-02 Sweat pad and methods of using same

Family Applications After (4)

Application Number Title Priority Date Filing Date
US16/986,266 Active 2036-02-25 US11298254B2 (en) 2015-12-16 2020-08-06 Sweat pad and methods of using same
US17/688,876 Active 2035-12-17 US11786389B2 (en) 2015-12-16 2022-03-07 Sweat pad and methods of using same
US18/464,269 Active US12239559B2 (en) 2015-12-16 2023-09-11 Sweat pad and methods of using same
US18/965,682 Pending US20250090357A1 (en) 2015-12-16 2024-12-02 Sweat pad and methods of using same

Country Status (8)

Country Link
US (5) US20170172781A1 (enExample)
EP (1) EP3389579A4 (enExample)
JP (1) JP2019508187A (enExample)
CN (1) CN108366881A (enExample)
AU (1) AU2016373824B2 (enExample)
CA (1) CA3008671A1 (enExample)
MX (1) MX2018007394A (enExample)
WO (1) WO2017105721A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD914205S1 (en) * 2015-12-16 2021-03-23 Hemispheres For All, Llc Absorbent pad
USD966502S1 (en) * 2015-12-16 2022-10-11 Hemispheres For All, Llc Absorbent pad

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170172781A1 (en) * 2015-12-16 2017-06-22 Thomas A. Muldowney Sweat pad and methods of using same

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4702237A (en) * 1985-01-11 1987-10-27 Gianopoulos Thomas J Hemorrhoid retainers
US5695484A (en) * 1995-12-12 1997-12-09 Cox; Brian J. Anal patch for fecal incontinence
US20020193766A1 (en) * 2001-06-12 2002-12-19 Gell Carol B. Sanitary napkin with adjustable length intergluteal strip
US20040167479A1 (en) * 2003-02-20 2004-08-26 The Procter & Gamble Company Hemorrhoid treatment pad
US6913573B1 (en) * 2003-04-21 2005-07-05 Dominic Anthony Viscomi Positive-pressure rectal incontinence pad
US20070031466A1 (en) * 2005-08-05 2007-02-08 Blurton David D Method, apparatus and system for preventing or reducing the severity of hemorrhoids
US20070260163A1 (en) * 2006-05-03 2007-11-08 Plexus Biomedical, Inc. Apparatus and Method of Inhibiting Perianal Tissue Damage
US7530973B2 (en) * 2004-05-27 2009-05-12 Uni-Charm Corporation Sanitary napkin having three-dimensional structure in intergluteal cleft-facing region
US20130197459A1 (en) * 2012-01-31 2013-08-01 Butterfly Health, Inc. Devices and methods for treating accidental bowel leakage
US20150216699A1 (en) * 2012-09-14 2015-08-06 Finn Kobke Hemorrhoidal device

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US44744A (en) 1864-10-18 Improvement in paper-pulp hats
US3211145A (en) 1961-07-12 1965-10-12 Rosenthal Sol Roy Toilet tissue
US5228853A (en) 1991-07-17 1993-07-20 E. I. Du Pont De Nemours And Company Method for determining a sensitive tooth
AU2172795A (en) * 1994-06-24 1996-01-11 Mcneil-Ppc, Inc. Method of reducing the coefficient of friction of absorbent products and wax coated products produced thereby
DE29705271U1 (de) * 1997-03-22 1998-02-19 Bauer, Nikolaus, 64668 Rimbach Slipeinlage für den Analausgang
US6673982B1 (en) * 1998-10-02 2004-01-06 Kimberly-Clark Worldwide, Inc. Absorbent article with center fill performance
US6716229B2 (en) * 1999-02-25 2004-04-06 Joseph Toth Hemorrhoid relief and anal hygiene device
JP2001327527A (ja) * 2000-03-14 2001-11-27 Fusae Aoki 衛生用部材とその製造方法
US7147628B2 (en) * 2000-10-02 2006-12-12 Sca Hygiene Products Ab Absorbent article with improved liquid-handling ability
US6311332B1 (en) 2000-11-22 2001-11-06 Jack Lien Hat having a window with replaceable patterns
US6554813B2 (en) * 2000-11-24 2003-04-29 Sca Hygiene Products Ab Absorbent intralabial sanitary protection device
CN1666727A (zh) * 2001-01-24 2005-09-14 宝洁公司 制造唇间吸收装置的方法
JP2002330992A (ja) * 2001-05-10 2002-11-19 Masami Yamamoto ウイング部付き液吸収性物品
US7195619B2 (en) 2002-12-31 2007-03-27 Manasek Francis J Absorbent article for protection against anal leakage
US20050182376A1 (en) 2004-02-17 2005-08-18 A-Fem Medical Corporation Anal hygienic pad and method of use
US7642395B2 (en) * 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
CN2803422Y (zh) * 2005-06-27 2006-08-09 彭洪云 一次性肛塞垫
WO2007073246A1 (en) 2005-12-20 2007-06-28 Sca Hygiene Products Ab New article
US7294350B2 (en) * 2006-03-21 2007-11-13 Marraccini Philip A Healing powder and method of use thereof
CA2679725C (en) * 2007-02-28 2015-07-07 Quantrx Biomedical Corporation Folded perineal pad
US8419699B2 (en) 2008-10-24 2013-04-16 TamiCare, Ltd. Absorbent pad
JP5649313B2 (ja) * 2010-02-26 2015-01-07 ユニ・チャーム株式会社 吸収性物品及び吸収性物品の製造方法
USD666296S1 (en) 2010-10-22 2012-08-28 Mussie Tekle Sibhatu Locator safety spacer clip
USD720848S1 (en) 2012-05-21 2015-01-06 Butterfly Health, Inc. Body liner for anal leakage
EP2811960B1 (en) 2012-01-31 2017-06-21 Attends Healthcare Products, Inc. Devices and methods for treating accidental bowel leakage
USD721170S1 (en) 2012-11-16 2015-01-13 Butterfly Health, Inc. Body liner for anal leakage
BR112014018716A8 (pt) 2012-01-31 2017-07-11 Butterfly Health Inc Dispositivos e métodos para tratar vazamento acidental do intestino
US8591488B2 (en) 2012-01-31 2013-11-26 Butterfly Health, Inc. Devices and methods for treating accidental bowel leakage
US9480608B2 (en) * 2012-10-31 2016-11-01 Kimberly-Clark Worldwide, Inc. Absorbent article with a fluid-entangled body facing material including a plurality of hollow projections
CN202920477U (zh) * 2012-11-27 2013-05-08 李伟 一种新型痔疮外用药贴
CN104523369B (zh) * 2015-01-16 2018-03-20 佛山市优特医疗科技有限公司 一种锥形伤口敷料
USD914205S1 (en) 2015-12-16 2021-03-23 Hemispheres For All, Llc Absorbent pad
US20170172781A1 (en) * 2015-12-16 2017-06-22 Thomas A. Muldowney Sweat pad and methods of using same

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4702237A (en) * 1985-01-11 1987-10-27 Gianopoulos Thomas J Hemorrhoid retainers
US5695484A (en) * 1995-12-12 1997-12-09 Cox; Brian J. Anal patch for fecal incontinence
US20020193766A1 (en) * 2001-06-12 2002-12-19 Gell Carol B. Sanitary napkin with adjustable length intergluteal strip
US20040167479A1 (en) * 2003-02-20 2004-08-26 The Procter & Gamble Company Hemorrhoid treatment pad
US6913573B1 (en) * 2003-04-21 2005-07-05 Dominic Anthony Viscomi Positive-pressure rectal incontinence pad
US7530973B2 (en) * 2004-05-27 2009-05-12 Uni-Charm Corporation Sanitary napkin having three-dimensional structure in intergluteal cleft-facing region
US20070031466A1 (en) * 2005-08-05 2007-02-08 Blurton David D Method, apparatus and system for preventing or reducing the severity of hemorrhoids
US20070260163A1 (en) * 2006-05-03 2007-11-08 Plexus Biomedical, Inc. Apparatus and Method of Inhibiting Perianal Tissue Damage
US20130197459A1 (en) * 2012-01-31 2013-08-01 Butterfly Health, Inc. Devices and methods for treating accidental bowel leakage
US20150216699A1 (en) * 2012-09-14 2015-08-06 Finn Kobke Hemorrhoidal device

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD914205S1 (en) * 2015-12-16 2021-03-23 Hemispheres For All, Llc Absorbent pad
USD930155S1 (en) 2015-12-16 2021-09-07 Hemispheres For All, Llc Absorbent pad
USD966502S1 (en) * 2015-12-16 2022-10-11 Hemispheres For All, Llc Absorbent pad

Also Published As

Publication number Publication date
AU2016373824B2 (en) 2021-10-21
JP2019508187A (ja) 2019-03-28
CN108366881A (zh) 2018-08-03
AU2016373824A1 (en) 2018-07-26
US20200375771A1 (en) 2020-12-03
EP3389579A1 (en) 2018-10-24
US12239559B2 (en) 2025-03-04
US20220192855A1 (en) 2022-06-23
CA3008671A1 (en) 2017-06-22
WO2017105721A1 (en) 2017-06-22
US11298254B2 (en) 2022-04-12
EP3389579A4 (en) 2020-07-22
MX2018007394A (es) 2018-09-21
US20230414392A1 (en) 2023-12-28
US20250090357A1 (en) 2025-03-20
US11786389B2 (en) 2023-10-17

Similar Documents

Publication Publication Date Title
US12239559B2 (en) Sweat pad and methods of using same
JP2022137110A (ja) 医療圧迫用接着フィルム包帯
JP3201606U (ja) 吸収性物品
US10213208B2 (en) Toroidal balloon for external or internal compression with unique insertion or removal
JP2016531671A (ja) 流体捕捉用装置及びその方法
US20140276294A1 (en) Multiple Bladder Deep Vein Thrombosis Prevention Garment
JP2016112408A (ja) 吸収性物品
CN105451699B (zh) 阴道插入组件
EP2704672A1 (en) Device for protecting hemorrhoids
TWI627943B (zh) Tampon
JP7377705B2 (ja) パンツ型吸収性物品
US20160158065A1 (en) Ring compression bandage
CN108778203A (zh) 具有稳定元件的外科绷带
RU2740180C2 (ru) Урологическая прокладка
CN102000389B (zh) 扩张器
JP2019508187A5 (enExample)
CN201949491U (zh) 扩张器
JP7783052B2 (ja) 脛骨足血管閉鎖バンド
CN103961208B (zh) 一种冷热两用外敷保护袋
CN209966679U (zh) 一种用于肠外露的折叠式保护性包扎装置
CN220801066U (zh) 阴道填塞棒及阴道护理套装
WO2021181853A1 (ja) パンツ型吸収性物品及びパンツ型吸収性物品の製造方法
CN104800961B (zh) 多功能阴道止血器
CN211095317U (zh) 一种产科护理垫
CN216169367U (zh) 一种用于痔疮手术病人的药物固定装置

Legal Events

Date Code Title Description
AS Assignment

Owner name: HEMISPHERES FOR ALL, LLC, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MULDOWNEY, THOMAS A;REEL/FRAME:043741/0052

Effective date: 20170926

AS Assignment

Owner name: HEMISPHERES FOR ALL, LLC, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SCHMITT, KARL R.;REEL/FRAME:044345/0153

Effective date: 20171130

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION